Maple Fung News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Equillium delivers new lupus data to Ono s doorstep

Equillium delivers new lupus data to Ono s doorstep
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Maple fungMono pharmaceuticalsMono pharmaceuticalsAurinia pharmaceuticalMedical officer maple fung

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New zealandMaple fungOno pharmaceutical co ltdMedicines partnershipEquillium incPeuropean league against rheumatismEuropean renal associationLupus networkOno pharmaceuticalEuropean renal association dialysisTransplant associationAccelerating medicines partnershipSystemic lupus erythematosusLupus nephritisBiocon limited

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kenneth kalunianMaple fungMichael mooreAmerican college of rheumatologyOno pharmaceutical co ltdLupus networkInvestor relations corporate communicationsEquillium incMedicines partnershipSchool of medicineExchange commissionMono pharmaceuticalsPeuropean league against rheumatismEuropean renal associationAmerican collegeOno pharmaceutical

Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates

$48.4 million in cash at the end of Q2 2023 expected to provide operating runway into 2025Fully prepaid and retired debt facilityAuthorized $7.5 million stock repurchase programLA JOLLA, Calif. (BUSINESS WIRE) $EQ Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding.

United statesMichael mooreMaple fungHead of corporate communicationsAmerican association of immunologistsClinical developmentMeeting of the european society for bloodEquillium incExchange commissionOno pharmaceutical co ltdBruce steelSecond quarterChief medical officerAmerican associationAnnual meetingEuropean society

Biocon Limited initiates clinical study of Itolizumab for Ulcerative Colitis in India

Biocon Limited initiates clinical study of Itolizumab for Ulcerative Colitis in India
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Maple fungSiddharth mittalSandeep athalyeBiocon biologicsEquillium incClinical developmentBiocon limitedUlcerative colitisDrugs controller generalManaging directorChief medical officerInflammatory bowel diseaseSenior vice president